Literature DB >> 22564840

Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae.

Dearbháile Morris, Edel McGarry, Meaghan Cotter, Virginie Passet, Maureen Lynch, Catherine Ludden, Margaret M Hannan, Sylvain Brisse, Martin Cormican.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22564840      PMCID： PMC3393432          DOI： 10.1128/AAC.00638-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  17 in total

Review 1.  Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae.

Authors:  Karen Bush
Journal:  Curr Opin Microbiol       Date:  2010-10-01       Impact factor: 7.934

Review 2.  Emerging carbapenemases: a global perspective.

Authors:  Timothy R Walsh
Journal:  Int J Antimicrob Agents       Date:  2010-11       Impact factor: 5.283

3.  Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

Authors:  Elisabetta Mantengoli; Francesco Luzzaro; Patrizia Pecile; Daniela Cecconi; Annalisa Cavallo; Letizia Attala; Alessandro Bartoloni; Gian Maria Rossolini
Journal:  Clin Infect Dis       Date:  2011-01-10       Impact factor: 9.079

4.  Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone.

Authors:  Dearbháile Morris; Fiona Boyle; Catherine Ludden; Iris Condon; James Hale; Nuala O'Connell; Lorraine Power; Teck Wee Boo; Hiran Dhanji; Christian Lavallee; Neil Woodford; Martin Cormican
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

5.  When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.

Authors:  Thierry Naas; Gaelle Cuzon; Olivier Gaillot; René Courcol; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

6.  Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131.

Authors:  Gisele Peirano; Paul C Schreckenberger; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

7.  First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011.

Authors:  D J O'Brien; C Wrenn; C Roche; L Rose; C Fenelon; A Flynn; V Murphy; S F FitzGerald; L E Fenelon; B Crowley; K Schaffer
Journal:  Euro Surveill       Date:  2011-07-21

Review 8.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.

Authors:  Benjamin A Rogers; Hanna E Sidjabat; David L Paterson
Journal:  J Antimicrob Chemother       Date:  2010-11-16       Impact factor: 5.790

9.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

Authors:  Olivier Clermont; Hiran Dhanji; Mathew Upton; Tarek Gibreel; Andrew Fox; David Boyd; Michael R Mulvey; Patrice Nordmann; Etienne Ruppé; Jean Louis Sarthou; Thierry Frank; Sophie Vimont; Guillaume Arlet; Catherine Branger; Neil Woodford; Erick Denamur
Journal:  J Antimicrob Chemother       Date:  2009-05-27       Impact factor: 5.790

Review 10.  Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.

Authors:  R G Masterton; A Galloway; G French; M Street; J Armstrong; E Brown; J Cleverley; P Dilworth; C Fry; A D Gascoigne; Alan Knox; Dilip Nathwani; Robert Spencer; Mark Wilcox
Journal:  J Antimicrob Chemother       Date:  2008-04-29       Impact factor: 5.790
View more
  10 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.

Authors:  Jesús Oteo; Adriana Ortega; Rosa Bartolomé; Germán Bou; Carmen Conejo; Marta Fernández-Martínez; Juan José González-López; Laura Martínez-García; Luis Martínez-Martínez; María Merino; Elisenda Miró; Marta Mora; Ferran Navarro; Antonio Oliver; Álvaro Pascual; Jesús Rodríguez-Baño; Guillermo Ruiz-Carrascoso; Patricia Ruiz-Garbajosa; Laura Zamorano; Verónica Bautista; María Pérez-Vázquez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

Review 3.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Complete Sequencing of Plasmids Containing blaOXA-163 and blaOXA-48 in Escherichia coli Sequence Type 131.

Authors:  Nicole Stoesser; Anna E Sheppard; Gisele Peirano; Robert Sebra; Tarah Lynch; Luke Anson; Andrew Kasarskis; Mary R Motyl; Derrick W Crook; Johann D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

5.  Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.

Authors:  Catherine Ludden; Martin Cormican; Akke Vellinga; James R Johnson; Bernie Austin; Dearbháile Morris
Journal:  BMC Infect Dis       Date:  2015-04-01       Impact factor: 3.090

6.  Emergence of diversity in carbapenemase-producing Escherichia coli ST131, England, January 2014 to June 2016.

Authors:  Nicholas Ellaby; Michel Doumith; Katie L Hopkins; Neil Woodford; Matthew J Ellington
Journal:  Euro Surveill       Date:  2019-09

7.  Global dissemination of a multidrug resistant Escherichia coli clone.

Authors:  Nicola K Petty; Nouri L Ben Zakour; Mitchell Stanton-Cook; Elizabeth Skippington; Makrina Totsika; Brian M Forde; Minh-Duy Phan; Danilo Gomes Moriel; Kate M Peters; Mark Davies; Benjamin A Rogers; Gordon Dougan; Jesús Rodriguez-Baño; Alvaro Pascual; Johann D D Pitout; Mathew Upton; David L Paterson; Timothy R Walsh; Mark A Schembri; Scott A Beatson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

8.  The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone.

Authors:  Minh-Duy Phan; Kate M Peters; Sohinee Sarkar; Samuel W Lukowski; Luke P Allsopp; Danilo Gomes Moriel; Maud E S Achard; Makrina Totsika; Vikki M Marshall; Mathew Upton; Scott A Beatson; Mark A Schembri
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

Review 9.  Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.

Authors:  Tim Downing
Journal:  Microorganisms       Date:  2015-05-20

Review 10.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.